| Managing drugs and devices in patients with permanent ventricular assist devices. | |
| | |
MedLine Citation:
|
PMID: 17761117 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Patients will be considered for destination mechanical circulatory support device (MCSD) implantation when all other organ-saving treatment options have failed and they are not eligible for heart transplantation. Current medical evidence suggests that only for those patients who are inotrope-dependent and therefore likely have a 1-year survival probability without MCSD implantation of less than 50%, MCSD intervention will add to survival and quality-of-life benefit. Suitable candidates for MCSD are those patients who have a high risk of dying from heart failure but acceptable noncardiac risk. Evaluation of patients for MCSD requires a systematic and critical review of all organ systems and of the psychosocial situation. Specifically, right ventricular function and risk of right ventricular failure should be evaluated before planning destination MCSD implantation. Treatment will focus on prompt recovery from MCSD implantation, maintaining optimal treatment for heart failure, and preventing/treating MCSD complications, including infection, bleeding, coagulopathy, right heart failure, and device dysfunction. MCSD programs should be organized as an advanced heart failure center directed by specialized heart failure cardiologists, surgeons expert at implant and management of MCSD, specialized nurses, social workers, psychologists, financial experts, and physical therapists. MCSD practice is based on a patient-centered theory, with an appropriate understanding of the respective roles of the physician and the patient during their iterative encounters in which the patient is an autonomous person making responsible personal health decisions while the health care team is providing continued expert and empathic counseling about various options, based on systematic outcomes research (eg, by participation in the Interagency Registry for Mechanically Assisted Circulatory Support - MCSD database ). |
| | |
Authors:
|
Martin Cadeiras; Manuel von Bayern; Mario C Deng |
Related Documents
:
|
430577 - Partial regeneration of the above-elbow amputated rat forelimb. ii. electrical and mech... 22833287 - The effect of er:yag laser irradiation on hydroxyapatite-coated implants and fluoride-m... 21047827 - Implantation technique of the centrimag biventricular assist device allowing ambulatory... 20853357 - Percutaneous retrieval of the locked helex septal occluder. 430577 - Partial regeneration of the above-elbow amputated rat forelimb. ii. electrical and mech... 17627957 - Possibilities of using human teeth for retrospective dosimetry: analysis of the techa r... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current treatment options in cardiovascular medicine Volume: 9 ISSN: 1092-8464 ISO Abbreviation: Curr Treat Options Cardiovasc Med Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-08-31 Completed Date: 2010-06-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815942 Medline TA: Curr Treat Options Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: 318-31 Citation Subset: - |
Affiliation:
|
Cardiac Transplantation Research, Division of Cardiology, Department of Medicine, Columbia University College of Physicians & Surgeons, New York Presbyterian Hospital, PH Room 1291, 622 W. 168th Street, New York, NY 10032, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thromboembolic Risk in the Patient with Heart Failure.
Next Document: Optimal use of diuretics in patients with heart failure.